INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Expedite Drug Development With An Integrated CDMO-CRO Model

  From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.

• Building A Clinical Research AI Governance Framework

  Learn how structured oversight, transparency, and collaboration help ensure compliance, reduce bias, and build trust while enabling innovation in increasingly data-driven trials.

• The Regulatory Governance Gap In Clinical Trial AI

  Regulators are no longer questioning whether AI belongs in clinical trials; however, they’re demanding a governed infrastructure that makes every AI-driven decision auditable and defensible.

• Navigating the Next Wave of CNS Development

  Learn how advances in biomarkers, AI, digital endpoints, and translational science can support more informed strategies across CNS drug development.

• A Practical Case For eCOA In Phase I Oncology Clinical Trials

  9/4/2026

  Phase I oncology teams can capture meaningful patient outcomes data without added complexity, building a foundation that eases later-phase eCOA demands.

• Increasing Participation In World-Class Cancer Research In Northwest Arkansas

  3/26/2026

  Discover how data automation and integrated screening help community cancer centers offer clinical research as a standard care option, ensuring all patients have access to the latest treatments.

• How AI Is Reshaping Trial Design, Execution, And Disclosure

  9/25/2025

  AI has quietly embedded itself into the operational heart of clinical development, where it is accelerating decisions, reducing manual burden, and improving outcomes.

• Navigating The Enrollment Bottleneck In Early Oncology Trials

  1/12/2026

  Slow oncology trial enrollment raises costs and delays progress. AI prescreening, patient-focused engagement, and early pharmacology studies help accelerate recruitment and optimize trial design.

• Breaking Barriers With PCR: Innovative Solutions For Clinical Trial Success

  9/3/2025

  This presentation brings together experts from Precision for Medicine, Avidity Biosciences, and Indaptus Therapeutics to examine the expanding role of PCR-based molecular monitoring.